View in EDS PDF Full Text

Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors.

Saved in:
Bibliographic Details
Title: Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors.
Authors: Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., Adib E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., Weise N; Moores Cancer Center, University of California San Diego, La Jolla, CA, United States., Curran C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., Stewart T; Moores Cancer Center, University of California San Diego, La Jolla, CA, United States., Freeman D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., Nassar AH; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Abou Alaiwi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States., Jain RK; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States., McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA, United States., Sonpavde G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline 23 Ave., DANA 1230, Boston, MA 02215, United States. Electronic address: GuruP_Sonpavde@dfci.harvard.edu.
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Aug; Vol. 20 (4), pp. 301-306. Date of Electronic Publication: 2022 Apr 29.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0682
DOI:10.1016/j.clgc.2022.04.012